<DOC>
<DOCNO>
EP-0014910
</DOCNO>
<TEXT>
<DATE>
19800903
</DATE>
<IPC-CLASSIFICATIONS>
A23L-1/34 A61K-31/23 A61K-31/21 <main>A61K-31/23</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
wholly acetylated monoglycerides for use for lowering of raised levels of cholesterol and/or neutral fats in human blood and process for production of pharmaceutical compositions for this purpose and dietetic foodstuffs containing them.
</TITLE>
<APPLICANT>
gatzen carl jacobde <sep>poethen hartmutde   <sep>sion heribert dr medde<sep>gatzen, carl-jacob<sep>poethen, hartmut, dr. med.<sep>sion, heribert, dr.med.<sep>gatzen, carl-jacobpannebäckerstrasse 20d-4000 düsseldorf 13de<sep>poethen, hartmut, dr. med.berger allee 3d-4000 düsseldorfde<sep>sion, heribert, dr.med.graf-adolf-platz 3d-4000 düsseldorf 1de<sep>gatzen, carl-jacob  <sep>poethen, hartmut, dr. med.<sep>sion, heribert, dr.med.<sep>
</APPLICANT>
<INVENTOR>
gatzen carl-jacob<sep>gatzen, carl-jacob<sep>gatzen, carl-jacobpannebäckerstrasse 20d-4000 düsseldorf 13de<sep>poethen, hartmut, dr. med.berger allee 3d-4000 düsseldorfde<sep>sion, heribert, dr.med.graf-adolf-platz 3d-4000 düsseldorf 1de<sep>gatzen, carl-jacob<sep>
</INVENTOR>
<ABSTRACT>
The invention relates to the novel use of fully acetylated monoglycerides of the general formula wherein one of the radicals R₁, R₂ and R₃ are the radical of a saturated or olefinically unsaturated fatty acid with 12 to 22 carbon atoms and the other two radicals acetyl groups, for lowering excessive cholesteroland / or neutral fat levels in the blood of humans and / or to overcome the treatment resistance of people with increased cholesterol and / or neutral fat blood levels against conventional pharmaceutical products for the treatment of such metabolic disorders.The invention further relates to this purpose, and such a fully acetylated monoglyceride-containing pharmaceutical preparations and dietetic close materials.
</ABSTRACT>
</TEXT>
</DOC>
